Wednesday, 22 December 2021

Medical Treatment News: Israeli Parkinson's treatment shows positive results, eyes FDA approval

 

Israeli Parkinson's treatment shows positive results, eyes FDA approval


P2B001 is a fixed-dose combination of extended-release formulations of pramipexole and rasagiline.  


No comments:

Post a Comment